Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, will sponsor a January 30 WoundSource webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment” led by Gregory Schultz, PhD, Professor of Obstetrics and Gynecology and Director of the Institute for Wound Research at the University of Florida.